These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10551862)

  • 1. A functional linker in human topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay.
    Stewart L; Ireton GC; Champoux JJ
    J Biol Chem; 1999 Nov; 274(46):32950-60. PubMed ID: 10551862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human topoisomerase I with a partial deletion of the linker region yields monomeric and dimeric enzymes that respond differently to camptothecin.
    Ireton GC; Stewart L; Parker LH; Champoux JJ
    J Biol Chem; 2000 Aug; 275(33):25820-30. PubMed ID: 10827183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstitution of human topoisomerase I by fragment complementation.
    Stewart L; Ireton GC; Champoux JJ
    J Mol Biol; 1997 Jun; 269(3):355-72. PubMed ID: 9199405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and biophysical analyses of recombinant forms of human topoisomerase I.
    Stewart L; Ireton GC; Parker LH; Madden KR; Champoux JJ
    J Biol Chem; 1996 Mar; 271(13):7593-601. PubMed ID: 8631793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of the human topoisomerase linker domain with the plasmodial counterpart renders the enzyme camptothecin resistant.
    Arnò B; D'Annessa I; Tesauro C; Zuccaro L; Ottaviani A; Knudsen B; Fiorani P; Desideri A
    PLoS One; 2013; 8(7):e68404. PubMed ID: 23844196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The domain organization of human topoisomerase I.
    Stewart L; Ireton GC; Champoux JJ
    J Biol Chem; 1996 Mar; 271(13):7602-8. PubMed ID: 8631794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.
    Wright CM; van der Merwe M; DeBrot AH; Bjornsti MA
    J Biol Chem; 2015 May; 290(19):12068-78. PubMed ID: 25795777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of the camptothecin resistance of Glu710Gly topoisomerase IB mutant analyzed in vitro and in silico.
    Tesauro C; Morozzo della Rocca B; Ottaviani A; Coletta A; Zuccaro L; Arnò B; D'Annessa I; Fiorani P; Desideri A
    Mol Cancer; 2013 Sep; 12(1):100. PubMed ID: 24004603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophane-205 of human topoisomerase I is essential for camptothecin inhibition of negative but not positive supercoil removal.
    Frøhlich RF; Veigaard C; Andersen FF; McClendon AK; Gentry AC; Andersen AH; Osheroff N; Stevnsner T; Knudsen BR
    Nucleic Acids Res; 2007; 35(18):6170-80. PubMed ID: 17827209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I.
    Fiorani P; Bruselles A; Falconi M; Chillemi G; Desideri A; Benedetti P
    J Biol Chem; 2003 Oct; 278(44):43268-75. PubMed ID: 12904303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA.
    Redinbo MR; Stewart L; Kuhn P; Champoux JJ; Hol WG
    Science; 1998 Mar; 279(5356):1504-13. PubMed ID: 9488644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin.
    van der Merwe M; Bjornsti MA
    J Biol Chem; 2008 Feb; 283(6):3305-3315. PubMed ID: 18056711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domains of human topoisomerase I and associated functions.
    Champoux JJ
    Prog Nucleic Acid Res Mol Biol; 1998; 60():111-32. PubMed ID: 9594573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pentapeptide signature motif plays a pivotal role in Leishmania DNA topoisomerase IB activity and camptothecin sensitivity.
    Prada CF; Alvarez-Velilla R; Diaz-González R; Prieto C; Pérez-Pertejo Y; Balaña-Fouce R; Reguera RM
    Biochim Biophys Acta; 2012 Dec; 1820(12):2062-71. PubMed ID: 23000572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution and functional characterization of the unusual bi-subunit type I DNA topoisomerase from Leishmania donovani.
    Das BB; Sen N; Ganguly A; Majumder HK
    FEBS Lett; 2004 May; 565(1-3):81-8. PubMed ID: 15135057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residues within the N-terminal domain of human topoisomerase I play a direct role in relaxation.
    Lisby M; Olesen JR; Skouboe C; Krogh BO; Straub T; Boege F; Velmurugan S; Martensen PM; Andersen AH; Jayaram M; Westergaard O; Knudsen BR
    J Biol Chem; 2001 Jun; 276(23):20220-7. PubMed ID: 11283003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures.
    Redinbo MR; Stewart L; Champoux JJ; Hol WG
    J Mol Biol; 1999 Sep; 292(3):685-96. PubMed ID: 10497031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermotoga maritima-Escherichia coli chimeric topoisomerases. Answers about involvement of the carboxyl-terminal domain in DNA topoisomerase I-mediated catalysis.
    Viard T; Cossard R; Duguet M; de La Tour CB
    J Biol Chem; 2004 Jul; 279(29):30073-80. PubMed ID: 15140883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in linker flexibility suppress DNA topoisomerase I mutant-induced cell lethality.
    Losasso C; Cretaio E; Palle K; Pattarello L; Bjornsti MA; Benedetti P
    J Biol Chem; 2007 Mar; 282(13):9855-9864. PubMed ID: 17276985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) polymerase-1 could facilitate the religation of topoisomerase I-linked DNA inhibited by camptothecin.
    Park SY; Cheng YC
    Cancer Res; 2005 May; 65(9):3894-902. PubMed ID: 15867389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.